FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...
FibroBiologics is pursuing a development program for FSdC spheroids with the goal of advancing to clinical trials. The data includes comprehensive preclinical pharmacology and efficacy assessments ...
Human lung fibroblasts stimulated with TGF-β1 to detect extracellular collagen I (pink), alpha-smooth muscle actin (α-SMA) (green), and cell nuclei (blue) as a measure of matrix production and ...
Rare inherited diseases affect an estimated 3.5–5.9% of the global population, with most being genetically acquired and presenting in childhood. Despite their impact, these disorders remain poorly ...
This article is based on a poster originally authored by Fiona Leslie, Chloe Whiting, and Megan Webster. Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive interstitial lung disease ...
Engineering student research on joint damage, arthritis, heart problems, and tissue defects were the subject of presentations at a major national conference. Six students and researchers from the ...
Senescence. It’s a beautiful-sounding word whose tones suggest it should be a perfume or an essential oil. But that’s not ...
Fibroblasts, cells that produce and organize the extracellular matrix (ECM) appear to be in cahoots with metastasizing tumor cells, according to research presented at the annual meeting of the ...
Hosted on MSN
Cells usually viewed as menders may harm the heart
Fibroblasts, cells that repair heart damage, might cause a cycle of stiffening and scarring in certain heart conditions. Subscribe to our newsletter for the latest sci-tech news updates. Dilated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback